These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18537099)

  • 1. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease.
    Wassink AM; Van Der Graaf Y; Soedamah-Muthu SS; Spiering W; Visseren FLj;
    Diab Vasc Dis Res; 2008 Jun; 5(2):114-22. PubMed ID: 18537099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome.
    van Kruijsdijk RC; van der Graaf Y; Peeters PH; Visseren FL;
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1267-77. PubMed ID: 23677576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases.
    Wassink AM; van der Graaf Y; Janssen KJ; Cook NR; Visseren FL;
    Eur J Prev Cardiol; 2012 Dec; 19(6):1486-95. PubMed ID: 22008749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease.
    Vlek AL; van der Graaf Y; Sluman MA; Moll FL; Visseren FL;
    J Vasc Surg; 2009 Jul; 50(1):61-9. PubMed ID: 19223144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waist circumference and metabolic risk factors have separate and additive effects on the risk of future Type 2 diabetes in patients with vascular diseases. A cohort study.
    Wassink AM; van der Graaf Y; van Haeften TW; Spiering W; Soedamah-Muthu SS; Visseren FL;
    Diabet Med; 2011 Aug; 28(8):932-40. PubMed ID: 21749443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leisure-time physical activity and risk of type 2 diabetes in patients with established vascular disease or poorly controlled vascular risk factors.
    Brouwer BG; van der Graaf Y; Soedamah-Muthu SS; Wassink AM; Visseren FL;
    Diabetes Res Clin Pract; 2010 Mar; 87(3):372-8. PubMed ID: 20047771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study.
    Hanley AJ; Karter AJ; Williams K; Festa A; D'Agostino RB; Wagenknecht LE; Haffner SM
    Circulation; 2005 Dec; 112(24):3713-21. PubMed ID: 16344402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome defined by modified International Diabetes Federation criteria and type 2 diabetes mellitus risk: a 9-year follow-up among the aged in Finland.
    Salminen M; Kuoppamäki M; Vahlberg T; Räihä I; Irjala K; Kivelä SL
    Diab Vasc Dis Res; 2013 Jan; 10(1):11-6. PubMed ID: 22461662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands.
    de León AC; Coello SD; González DA; Díaz BB; Rodríguez JC; Hernández AG; Aguirre-Jaime A; Pérez Mdel C
    Diabet Med; 2012 Mar; 29(3):399-403. PubMed ID: 21883429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and incidence of asthma in adults: the HUNT study.
    Brumpton BM; Camargo CA; Romundstad PR; Langhammer A; Chen Y; Mai XM
    Eur Respir J; 2013 Dec; 42(6):1495-502. PubMed ID: 23845717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study.
    Hanefeld M; Koehler C; Gallo S; Benke I; Ott P
    Cardiovasc Diabetol; 2007 Apr; 6():13. PubMed ID: 17462080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and the development of type 2 diabetes among professionals living in Beijing, China.
    Zeng P; Zhu X; Zhang Y; Wang S; Zhang T
    Diabetes Res Clin Pract; 2011 Nov; 94(2):299-304. PubMed ID: 21920619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
    Lucove J; Vupputuri S; Heiss G; North K; Russell M
    Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Wassink AM; van der Graaf Y; Olijhoek JK; Visseren FL;
    Eur Heart J; 2008 Jan; 29(2):213-23. PubMed ID: 18199567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and incident end-stage peripheral vascular disease: a 14-year follow-up study in elderly Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Diabetes Care; 2007 Dec; 30(12):3099-104. PubMed ID: 17848614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.